Bivalent Protein-Based Vaccine Against RSV Administered During Pregnancy Safe, Effective, Trial Indicates
April 28, 2022
MedPage Today (4/27, Walker) reports, “A bivalent protein-based vaccine against respiratory syncytial virus (RSV) administered during pregnancy was safe and led to higher neutralizing antibody responses in mothers, as well as evidence of protection in the...